Thermo Fisher Scientific Completes Acquisition of Patheon | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
Thermo Fisher To Buy CDMO Firm Patheon In $7.2 Bln Deal
Thermo Fisher Scientific Pharma Services Global Network